The findings show diligence from the FDA and a need for clinicians to discuss risks, benefits, and unknowns with patients before using drugs with accelerated approval.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/safety-actions-common-fast-track-cancer-drugs-2026a10002u2?src=rss
Author :
Publish date : 2026-01-29 09:38:00
Copyright for syndicated content belongs to the linked Source.
